Margins matter. The more Illumina
Here's the current margin snapshot for Illumina over the trailing 12 months: Gross margin is 68.3%, while operating margin is 24.3% and net margin is 8.2%.
Unfortunately, a look at the most recent numbers doesn't tell us much about where Illumina has been, or where it's going. A company with rising gross and operating margins often fuels its growth by increasing demand for its products. If it sells more units while keeping costs in check, its profitability increases. Conversely, a company with gross margins that inch downward over time is often losing out to competition, and possibly engaging in a race to the bottom on prices. If it can't make up for this problem by cutting costs -- and most companies can't -- then both the business and its shares face a decidedly bleak outlook.
Of course, over the short term, the kind of economic shocks we recently experienced can drastically affect a company's profitability. That's why I like to look at five fiscal years' worth of margins, along with the results for the trailing 12 months, the last fiscal year, and last fiscal quarter. You can't always reach a hard conclusion about your company's health, but you can better understand what to expect, and what to watch.
Here's the margin picture for Illumina over the past few years.
Source: S&P Capital IQ. Dollar amounts in millions. FY = fiscal year. TTM = trailing 12 months.
Because of seasonality in some businesses, the numbers for the last period on the right -- the TTM figures -- aren't always comparable to the FY results preceding them. To compare quarterly margins to their prior-year levels, consult this chart.
Source: S&P Capital IQ. Dollar amounts in millions. FQ = fiscal quarter.
Here's how the stats break down:
- Over the past five years, gross margin peaked at 69.1% and averaged 66.6%. Operating margin peaked at 24.3% and averaged 20.7%. Net margin peaked at 13.8% and averaged -7.7%.
- TTM gross margin is 68.3%, 170 basis points better than the five-year average. TTM operating margin is 24.3%, 360 basis points better than the five-year average. TTM net margin is 8.2%, 1,590 basis points better than the five-year average.
With recent TTM operating margins exceeding historical averages, Illumina looks like it is doing fine.
- Add Illumina to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Motley Fool newsletter services have recommended buying shares of Illumina. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
What Happened in the Stock Market Today
On a record day for the indexes, Illumina stock rose on a product announcement and positive outlook, and e.l.f. Beauty fell following a lowered growth forecast.
5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
The gene-sequencing leader had plenty of good news to announce at the major healthcare conference this week.
Better Buy: Illumina, Inc. vs. Thermo Fisher Scientific
Which stock wins in a head-to-head match-up between these two gene-sequencing leaders?